Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer

Ross-Innes CS, Stark R, Holmes KA, Schmidt D, Spyrou C, Russell R, Massie CE, Vowler SL, Eldridge M, Carroll JS

Published January 15, 2010 Genes & development, 24(2), 171-82
DOI 10.1101/gad.552910 PMID 20080953 PMC PMC2807352

Abstract

Retinoic acid receptor-alpha (RAR alpha) is a known estrogen target gene in breast cancer cells. The consequence of RAR alpha induction by estrogen was previously unknown. We now show that RAR alpha is required for efficient estrogen receptor-alpha (ER)-mediated transcription and cell proliferation. RAR alpha can interact with ER-binding sites, but this occurs in an ER-dependent manner, providing a novel role for RAR alpha that is independent of its classic role. We show, on a genome-wide scale, that RAR alpha and ER can co-occupy regulatory regions together within the chromatin. This transcriptionally active co-occupancy and dependency occurs when exposed to the predominant breast cancer hormone, estrogen--an interaction that is promoted by the estrogen-ER induction of RAR alpha. These findings implicate RAR alpha as an essential component of the ER complex, potentially by maintaining ER-cofactor interactions, and suggest that different nuclear receptors can cooperate for effective transcriptional activity in breast cancer cells.

Related research

Caryn S Ross-Innes, Rory Stark, Kelly A Holmes, Dominic Schmidt, Christiana Spyrou, Roslin Russell, Charlie E Massie, Sarah L Vowler, Matthew Eldridge, Jason S Carroll
C Ross-Innes, R Stark, K Holmes, D Schmidt, C Spyrou, R Russell, Charles Massie, C Massie, S Vowler, Matt Eldridge, M Eldridge, J Carroll
PMID 20080953 20080953 DOI 10.1101/gad.552910 10.1101/gad.552910 Ross-Innes et al. 2010, Ross-Innes 2010